Angiotensin II does not influence expression of sarcoplasmic reticulum Ca2+ ATPase in atrial myocytes

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 10, Issue 3, 2009, Pages 121-126

  Wu, Cho Kai ^a   Tseng, Chuen Den ^a   Huang, Yin Tsen ^b   Hsieh, Chia Shan ^a   Tsai, Wei Shan ^a   Lin, Jiunn Lee ^a   Chiang, Fu Tien ^a   Tsai, Chia Ti ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Angiotensin II; HL 1 cardiomyocytes; Promoter; Sarcoplasmic reticulum Ca2+ ATPase; Transcriptional regulation

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ANGIOTENSIN II; LUCIFERASE; MESSENGER RNA;

ARTICLE; BINDING SITE; CALCIUM CELL LEVEL; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN CELL; MUSCLE CELL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; BINDING SITES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEART ATRIA; MICE; MYOCYTES, CARDIAC; PROMOTER REGIONS, GENETIC; RATS; RNA, MESSENGER; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; TRANSFECTION;

EID: 69849098027     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/1470320309342732     Document Type: Article

References (32)

1. Periasamy M., Huke S. SERCA pump level is a critical determinant of Ca(2+) homeostasis and cardiac contractility. J Mol Cell Cardiol 2001;33:1053-63.
2. Ver Heyen M., Heymans S., Antoons G. et al. Replacement of the muscle-specific sarcoplasmic reticulum Ca(2+)-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart. Circ Res 2001;89:838-46.
3. Brilla CG, Pick R., Tan LB et al. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 1990;67:1355-64.
4. Ohkusa T., Ueyama T., Yamada J. et al. Alterations in cardiac sarcoplasmic reticulum Ca2+ regulatory proteins in the atrial tissue of patients with chronic atrial fibrillation. J Am Coll Cardiol 1999;34:255-63.
5. Lai LP, Su MJ, Lin JL et al. Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: An insight into the mechanism of atrial electrical remodeling. J Am Coll Cardiol 1999;33:1231-7.
6. Cao K., Xia X., Shan Q. et al. Changes of sarcoplasmic reticular Ca(2+)- ATPase and IP(3)-I receptor mRNA expression in patients with atrial fibrillation. Chin Med J (Engl) 2002;115:664-7.
7. Ju H., Scammel-La Fleur T., Dixon IM Altered mRNA abundance of calcium transport genes in cardiac myocytes induced by angiotensin II. J Mol Cell Cardiol 1996;28:1119-28.
8. Flesch M., Schiffer F., Zolk O. et al. Angiotensin receptor antagonism and angiotensin converting enzyme inhibition improve diastolic dysfunction and Ca(2+)-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy. J Hypertens 1997;15:1001-09.
9. Tsai CT, Wang DL, Chen WP et al. Angiotensin II increases expression of alpha1c subunit of L-type calcium channel through a reactive oxygen species and cAMP response element-binding protein-dependent pathway in HL-1 myocytes. Circ Res 2007;100:1476-85.
10. Claycomb WC, Lanson NA, Jr, Stallworth BS et al. HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A 1998;95:2979-84.
11. Tsai CT, Lai LP, Hwang JJ et al. Renin-angiotensin system component expression in the HL-1 atrial cell line and in a pig model of atrial fibrillation. J Hypertens 2008;26:570-82.
12. Xiao HD, Fuchs S., Campbell DJ et al. Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. Am J Pathol 2004;165:1019-32.
13. Lijnen P., Petrov V., van Pelt J. et al. Inhibition of superoxide dismutase induces collagen production in cardiac fibroblasts. Am J Hypertens 2008;21:1129-36.
14. Zhou J., Xu X., Liu JJ et al. Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes. Clin Exp Pharmacol Physiol 2007;34:1191-8.
15. Trivieri MG, Oudit GY, Sah R. et al. Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction. Proc Natl Acad Sci U S A 2006;103:6043-8.
16. Lin CC, Lin JL, Lin CS et al. Activation of the calcineurin-nuclear factor of activated T-cell signal transduction pathway in atrial fibrillation. Chest 2004;126:1926-32.
17. Terentyev D., Viatchenko-Karpinski S., Gyorke I. et al. Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: Mechanism for hereditary arrhythmia. Proc Natl Acad Sci U S A 2003;100:11759-64.
18. He H., Giordano FJ, Hilal-Dandan R. et al. Overexpression of the rat sarcoplasmic reticulum Ca2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation. J Clin Invest 1997;100:380-9.
19. Ausma J., Dispersyn GD, Duimel H. et al. Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation. J Mol Cell Cardiol 2000;32:355-64.
20. Sun H., Chartier D., Leblanc N. et al. Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes. Cardiovasc Res 2001;49:751-61.
21. Shinagawa K., Mitamura H., Ogawa S. et al. Effects of inhibiting Na(+)/ H(+)-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling. Cardiovasc Res 2002;54:438-46.
22. Nakashima H., Kumagai K., Urata H. et al. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 2000;101:2612-17.
23. Ducharme A., Swedberg K., Pfeffer MA et al. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Am Heart J 2006;152:86-92.
24. Schmieder RE, Kjeldsen SE, Julius S. et al. Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: The VALUE trial. J Hypertens 2008;26:403-11.
25. Vermes E., Tardif JC, Bourassa MG et al. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: Insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation 2003;107:2926-31.
26. Healey JS, Baranchuk A., Crystal E. et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: A meta-analysis. J Am Coll Cardiol 2005;45:1832-9.
27. Madrid AH, Bueno MG, Rebollo JM et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: A prospective and randomized study. Circulation 2002;106:331-6.
28. Gassanov N., Brandt MC, Michels G. et al. Angiotensin II-induced changes of calcium sparks and ionic currents in human atrial myocytes: Potential role for early remodeling in atrial fibrillation. Cell Calcium 2006;39:175-86.
29. Komuro I., Yazaki Y. Control of cardiac gene expression by mechanical stress. Annu Rev Physiol 1993;55:55-75.
30. Villegas S., Villarreal FJ, Dillmann WH Leukemia inhibitory factor and interleukin-6 downregulate sarcoplasmic reticulum Ca2+ ATPase (SERCA2) in cardiac myocytes. Basic Res Cardiol 2000;95:47-54.
31. Shah RD, Gonzales F., Golez E. et al. The antidiabetic agent rosiglitazone upregulates SERCA2 and enhances TNF-alpha- and LPS-induced NF-kappaB-dependent transcription and TNF-alphainduced IL-6 secretion in ventricular myocytes. Cell Physiol Biochem 2005;15:41-50.
32. Vangheluwe P., Schuermans M., Zador E. et al. Sarcolipin and phospholamban mRNA and protein expression in cardiac and skeletal muscle of different species. Biochem J 2005;359:151-9.